📰 Spring Pharmaceutical News
Spring Pharmaceutical News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Spring Pharmaceutical. Real-time updates on events, politics, business and more.
April 13, 2023
/PRNewswire/ -- The motion sickness drugs market size is forecasted to increase by USD 119.64 million from 2021 to 2026, at a CAGR of 4.15%, according to the...
April 12, 2023
/PRNewswire/ -- The antacids market size is forecasted to increase by USD 712.45 million from 2021 to 2026, at a CAGR of 3.37%, according to the recent market...
October 1, 2022
/PRNewswire/ -- Technavios latest offering, the Motion Sickness Drugs Market report provides a detailed analysis of the competitive scenario and the market...
June 24, 2022
/PRNewswire/ -- The latest market analysis report titled Antacids Market by Type and Geography - Forecast and Analysis 2022-2026 has been recently added to...
May 30, 2022
Global Neutropenia Treatment Market To Be Driven By Increasing Awareness Of Neutropenia And Side-Effects Of Chemotherapy During The Forecast Period
May 11, 2022
Global Neutropenia Treatment Market To Be Driven By Increasing Awareness Of Neutropenia And Side-Effects Of Chemotherapy During The Forecast Period Of 2022
December 1, 2021
BeyondSpring Pharmaceuticals said the FDA wants another clinical trial to demonstrate patient benefit for its drug, a small molecule developed to treat a dangerous and life-threatening complication of chemotherapy. Shares of the biotech plunged more than 60% after the FDA’s complete response letter was announced.